Technical Analysis for SEPN - Septerna, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | N/A |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Hot IPO Pullback | Bullish Swing Setup | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Multiple of Ten Bullish | Other | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | -3.52% | |
| New 52 Week Low | Weakness | -3.52% | |
| Multiple of Ten Bullish | Other | -3.52% | |
| Gapped Up | Strength | -3.52% |
| Alert | Time |
|---|---|
| Gap Down Closed | about 11 hours ago |
| Down 5% | about 12 hours ago |
| Fell Below Previous Day's Low | about 12 hours ago |
| New 52 Week Low | about 12 hours ago |
| 60 Minute Opening Range Breakdown | about 13 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.
Keywords: Biotechnology Immunology Drug Discovery Inflammation Metabolic Disease Endocrinology
Classification
Keywords: Biotechnology Immunology Drug Discovery Inflammation Metabolic Disease Endocrinology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 25.6235 |
| 52 Week Low | 19.56 |
| Average Volume | 339,873 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 0.00 |
| 10-Day Moving Average | 0.00 |
| Average True Range | 0.00 |
| RSI (14) | 0.00 |
| ADX | 0.0 |
| +DI | 0.00 |
| -DI | 0.00 |
| Chandelier Exit (Long, 3 ATRs) | N/A |
| Chandelier Exit (Short, 3 ATRs) | N/A |
| Upper Bollinger Bands | 0.00 |
| Lower Bollinger Band | 0.00 |
| Percent B (%b) | 0.0 |
| BandWidth | 0.00 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.0 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 22.00 | ||||
| Resistance 3 (R3) | 22.07 | 21.47 | 21.67 | ||
| Resistance 2 (R2) | 21.47 | 20.97 | 21.44 | 21.56 | |
| Resistance 1 (R1) | 20.75 | 20.66 | 20.45 | 20.68 | 21.45 |
| Pivot Point | 20.15 | 20.15 | 20.01 | 20.12 | 20.15 |
| Support 1 (S1) | 19.43 | 19.65 | 19.13 | 19.36 | 18.59 |
| Support 2 (S2) | 18.83 | 19.34 | 18.80 | 18.48 | |
| Support 3 (S3) | 18.11 | 18.83 | 18.37 | ||
| Support 4 (S4) | 18.04 |
